nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.102	0.248	CbGbCtD
Paricalcitol—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0776	0.188	CbGbCtD
Paricalcitol—CYP3A4—Betamethasone—ankylosing spondylitis	0.0666	0.161	CbGbCtD
Paricalcitol—CYP3A4—Prednisolone—ankylosing spondylitis	0.0657	0.159	CbGbCtD
Paricalcitol—CYP3A4—Prednisone—ankylosing spondylitis	0.0621	0.15	CbGbCtD
Paricalcitol—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0387	0.0937	CbGbCtD
Paricalcitol—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000984	0.00168	CcSEcCtD
Paricalcitol—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000984	0.00168	CcSEcCtD
Paricalcitol—Discomfort—Triamcinolone—ankylosing spondylitis	0.000983	0.00168	CcSEcCtD
Paricalcitol—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000981	0.00167	CcSEcCtD
Paricalcitol—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000973	0.00166	CcSEcCtD
Paricalcitol—Angioedema—Dexamethasone—ankylosing spondylitis	0.000969	0.00165	CcSEcCtD
Paricalcitol—Angioedema—Betamethasone—ankylosing spondylitis	0.000969	0.00165	CcSEcCtD
Paricalcitol—Angiopathy—Prednisone—ankylosing spondylitis	0.000962	0.00164	CcSEcCtD
Paricalcitol—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00096	0.00164	CcSEcCtD
Paricalcitol—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00096	0.00164	CcSEcCtD
Paricalcitol—Immune system disorder—Prednisone—ankylosing spondylitis	0.000958	0.00163	CcSEcCtD
Paricalcitol—Malaise—Dexamethasone—ankylosing spondylitis	0.000956	0.00163	CcSEcCtD
Paricalcitol—Malaise—Betamethasone—ankylosing spondylitis	0.000956	0.00163	CcSEcCtD
Paricalcitol—Oedema—Triamcinolone—ankylosing spondylitis	0.000954	0.00163	CcSEcCtD
Paricalcitol—Vertigo—Betamethasone—ankylosing spondylitis	0.000953	0.00162	CcSEcCtD
Paricalcitol—Vertigo—Dexamethasone—ankylosing spondylitis	0.000953	0.00162	CcSEcCtD
Paricalcitol—Syncope—Dexamethasone—ankylosing spondylitis	0.000951	0.00162	CcSEcCtD
Paricalcitol—Syncope—Betamethasone—ankylosing spondylitis	0.000951	0.00162	CcSEcCtD
Paricalcitol—Arrhythmia—Prednisone—ankylosing spondylitis	0.000948	0.00162	CcSEcCtD
Paricalcitol—Infection—Triamcinolone—ankylosing spondylitis	0.000948	0.00161	CcSEcCtD
Paricalcitol—Sweating—Methotrexate—ankylosing spondylitis	0.000947	0.00161	CcSEcCtD
Paricalcitol—Infection—Methylprednisolone—ankylosing spondylitis	0.000945	0.00161	CcSEcCtD
Paricalcitol—Shock—Triamcinolone—ankylosing spondylitis	0.000938	0.0016	CcSEcCtD
Paricalcitol—Insomnia—Prednisolone—ankylosing spondylitis	0.000938	0.0016	CcSEcCtD
Paricalcitol—Alopecia—Prednisone—ankylosing spondylitis	0.000937	0.0016	CcSEcCtD
Paricalcitol—Shock—Methylprednisolone—ankylosing spondylitis	0.000936	0.0016	CcSEcCtD
Paricalcitol—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000933	0.00159	CcSEcCtD
Paricalcitol—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000932	0.00159	CcSEcCtD
Paricalcitol—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000932	0.00159	CcSEcCtD
Paricalcitol—Epistaxis—Methotrexate—ankylosing spondylitis	0.000931	0.00159	CcSEcCtD
Paricalcitol—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000931	0.00159	CcSEcCtD
Paricalcitol—Mental disorder—Prednisone—ankylosing spondylitis	0.000929	0.00158	CcSEcCtD
Paricalcitol—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000924	0.00158	CcSEcCtD
Paricalcitol—Malnutrition—Prednisone—ankylosing spondylitis	0.000923	0.00157	CcSEcCtD
Paricalcitol—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000922	0.00157	CcSEcCtD
Paricalcitol—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00092	0.00157	CcSEcCtD
Paricalcitol—Hypertension—Dexamethasone—ankylosing spondylitis	0.000915	0.00156	CcSEcCtD
Paricalcitol—Hypertension—Betamethasone—ankylosing spondylitis	0.000915	0.00156	CcSEcCtD
Paricalcitol—Myalgia—Dexamethasone—ankylosing spondylitis	0.000903	0.00154	CcSEcCtD
Paricalcitol—Myalgia—Betamethasone—ankylosing spondylitis	0.000903	0.00154	CcSEcCtD
Paricalcitol—Anxiety—Dexamethasone—ankylosing spondylitis	0.0009	0.00153	CcSEcCtD
Paricalcitol—Anxiety—Betamethasone—ankylosing spondylitis	0.0009	0.00153	CcSEcCtD
Paricalcitol—Discomfort—Betamethasone—ankylosing spondylitis	0.000892	0.00152	CcSEcCtD
Paricalcitol—Discomfort—Dexamethasone—ankylosing spondylitis	0.000892	0.00152	CcSEcCtD
Paricalcitol—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000889	0.00152	CcSEcCtD
Paricalcitol—Pain—Prednisolone—ankylosing spondylitis	0.000887	0.00151	CcSEcCtD
Paricalcitol—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00088	0.0015	CcSEcCtD
Paricalcitol—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000875	0.00149	CcSEcCtD
Paricalcitol—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000869	0.00148	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000869	0.00148	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000867	0.00148	CcSEcCtD
Paricalcitol—Oedema—Dexamethasone—ankylosing spondylitis	0.000865	0.00147	CcSEcCtD
Paricalcitol—Oedema—Betamethasone—ankylosing spondylitis	0.000865	0.00147	CcSEcCtD
Paricalcitol—Insomnia—Triamcinolone—ankylosing spondylitis	0.000863	0.00147	CcSEcCtD
Paricalcitol—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000861	0.00147	CcSEcCtD
Paricalcitol—Infection—Dexamethasone—ankylosing spondylitis	0.00086	0.00147	CcSEcCtD
Paricalcitol—Infection—Betamethasone—ankylosing spondylitis	0.00086	0.00147	CcSEcCtD
Paricalcitol—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000857	0.00146	CcSEcCtD
Paricalcitol—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000856	0.00146	CcSEcCtD
Paricalcitol—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000855	0.00146	CcSEcCtD
Paricalcitol—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000854	0.00146	CcSEcCtD
Paricalcitol—Anaemia—Prednisone—ankylosing spondylitis	0.000853	0.00145	CcSEcCtD
Paricalcitol—Shock—Dexamethasone—ankylosing spondylitis	0.000851	0.00145	CcSEcCtD
Paricalcitol—Shock—Betamethasone—ankylosing spondylitis	0.000851	0.00145	CcSEcCtD
Paricalcitol—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00085	0.00145	CcSEcCtD
Paricalcitol—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000849	0.00145	CcSEcCtD
Paricalcitol—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000849	0.00145	CcSEcCtD
Paricalcitol—Agitation—Prednisone—ankylosing spondylitis	0.000849	0.00145	CcSEcCtD
Paricalcitol—Angioedema—Prednisone—ankylosing spondylitis	0.000844	0.00144	CcSEcCtD
Paricalcitol—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00084	0.00143	CcSEcCtD
Paricalcitol—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000838	0.00143	CcSEcCtD
Paricalcitol—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000837	0.00143	CcSEcCtD
Paricalcitol—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000837	0.00143	CcSEcCtD
Paricalcitol—Malaise—Prednisone—ankylosing spondylitis	0.000833	0.00142	CcSEcCtD
Paricalcitol—Vertigo—Prednisone—ankylosing spondylitis	0.00083	0.00141	CcSEcCtD
Paricalcitol—Eye disorder—Methotrexate—ankylosing spondylitis	0.000828	0.00141	CcSEcCtD
Paricalcitol—Syncope—Prednisone—ankylosing spondylitis	0.000828	0.00141	CcSEcCtD
Paricalcitol—Anorexia—Dexamethasone—ankylosing spondylitis	0.000825	0.00141	CcSEcCtD
Paricalcitol—Anorexia—Betamethasone—ankylosing spondylitis	0.000825	0.00141	CcSEcCtD
Paricalcitol—Urticaria—Prednisolone—ankylosing spondylitis	0.000824	0.0014	CcSEcCtD
Paricalcitol—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000823	0.0014	CcSEcCtD
Paricalcitol—Fatigue—Triamcinolone—ankylosing spondylitis	0.000822	0.0014	CcSEcCtD
Paricalcitol—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00082	0.0014	CcSEcCtD
Paricalcitol—Pain—Triamcinolone—ankylosing spondylitis	0.000816	0.00139	CcSEcCtD
Paricalcitol—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000812	0.00138	CcSEcCtD
Paricalcitol—Hypotension—Dexamethasone—ankylosing spondylitis	0.000809	0.00138	CcSEcCtD
Paricalcitol—Hypotension—Betamethasone—ankylosing spondylitis	0.000809	0.00138	CcSEcCtD
Paricalcitol—Angiopathy—Methotrexate—ankylosing spondylitis	0.000804	0.00137	CcSEcCtD
Paricalcitol—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000801	0.00136	CcSEcCtD
Paricalcitol—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000799	0.00136	CcSEcCtD
Paricalcitol—Hypertension—Prednisone—ankylosing spondylitis	0.000797	0.00136	CcSEcCtD
Paricalcitol—Chills—Methotrexate—ankylosing spondylitis	0.000795	0.00136	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000788	0.00134	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000788	0.00134	CcSEcCtD
Paricalcitol—Myalgia—Prednisone—ankylosing spondylitis	0.000786	0.00134	CcSEcCtD
Paricalcitol—Arthralgia—Prednisone—ankylosing spondylitis	0.000786	0.00134	CcSEcCtD
Paricalcitol—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000786	0.00134	CcSEcCtD
Paricalcitol—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000784	0.00134	CcSEcCtD
Paricalcitol—Anxiety—Prednisone—ankylosing spondylitis	0.000783	0.00134	CcSEcCtD
Paricalcitol—Alopecia—Methotrexate—ankylosing spondylitis	0.000783	0.00134	CcSEcCtD
Paricalcitol—Insomnia—Betamethasone—ankylosing spondylitis	0.000783	0.00133	CcSEcCtD
Paricalcitol—Insomnia—Dexamethasone—ankylosing spondylitis	0.000783	0.00133	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000781	0.00133	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000778	0.00133	CcSEcCtD
Paricalcitol—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000777	0.00132	CcSEcCtD
Paricalcitol—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000777	0.00132	CcSEcCtD
Paricalcitol—Discomfort—Prednisone—ankylosing spondylitis	0.000777	0.00132	CcSEcCtD
Paricalcitol—Mental disorder—Methotrexate—ankylosing spondylitis	0.000777	0.00132	CcSEcCtD
Paricalcitol—Malnutrition—Methotrexate—ankylosing spondylitis	0.000772	0.00132	CcSEcCtD
Paricalcitol—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000764	0.0013	CcSEcCtD
Paricalcitol—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000762	0.0013	CcSEcCtD
Paricalcitol—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000762	0.0013	CcSEcCtD
Paricalcitol—Urticaria—Triamcinolone—ankylosing spondylitis	0.000758	0.00129	CcSEcCtD
Paricalcitol—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000756	0.00129	CcSEcCtD
Paricalcitol—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000756	0.00129	CcSEcCtD
Paricalcitol—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000754	0.00129	CcSEcCtD
Paricalcitol—Oedema—Prednisone—ankylosing spondylitis	0.000754	0.00128	CcSEcCtD
Paricalcitol—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000752	0.00128	CcSEcCtD
Paricalcitol—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000752	0.00128	CcSEcCtD
Paricalcitol—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000752	0.00128	CcSEcCtD
Paricalcitol—Infection—Prednisone—ankylosing spondylitis	0.000749	0.00128	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000747	0.00127	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000747	0.00127	CcSEcCtD
Paricalcitol—Back pain—Methotrexate—ankylosing spondylitis	0.000746	0.00127	CcSEcCtD
Paricalcitol—Fatigue—Dexamethasone—ankylosing spondylitis	0.000746	0.00127	CcSEcCtD
Paricalcitol—Fatigue—Betamethasone—ankylosing spondylitis	0.000746	0.00127	CcSEcCtD
Paricalcitol—Shock—Prednisone—ankylosing spondylitis	0.000741	0.00126	CcSEcCtD
Paricalcitol—Pain—Dexamethasone—ankylosing spondylitis	0.00074	0.00126	CcSEcCtD
Paricalcitol—Pain—Betamethasone—ankylosing spondylitis	0.00074	0.00126	CcSEcCtD
Paricalcitol—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000739	0.00126	CcSEcCtD
Paricalcitol—Skin disorder—Prednisone—ankylosing spondylitis	0.000732	0.00125	CcSEcCtD
Paricalcitol—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000729	0.00124	CcSEcCtD
Paricalcitol—Anorexia—Prednisone—ankylosing spondylitis	0.000718	0.00122	CcSEcCtD
Paricalcitol—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000716	0.00122	CcSEcCtD
Paricalcitol—Anaemia—Methotrexate—ankylosing spondylitis	0.000713	0.00122	CcSEcCtD
Paricalcitol—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000713	0.00122	CcSEcCtD
Paricalcitol—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000713	0.00122	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000708	0.00121	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000708	0.00121	CcSEcCtD
Paricalcitol—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000703	0.0012	CcSEcCtD
Paricalcitol—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000701	0.00119	CcSEcCtD
Paricalcitol—Malaise—Methotrexate—ankylosing spondylitis	0.000696	0.00119	CcSEcCtD
Paricalcitol—Vertigo—Methotrexate—ankylosing spondylitis	0.000693	0.00118	CcSEcCtD
Paricalcitol—Leukopenia—Methotrexate—ankylosing spondylitis	0.000691	0.00118	CcSEcCtD
Paricalcitol—Urticaria—Dexamethasone—ankylosing spondylitis	0.000687	0.00117	CcSEcCtD
Paricalcitol—Urticaria—Betamethasone—ankylosing spondylitis	0.000687	0.00117	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000687	0.00117	CcSEcCtD
Paricalcitol—Dizziness—Prednisolone—ankylosing spondylitis	0.000686	0.00117	CcSEcCtD
Paricalcitol—Asthenia—Triamcinolone—ankylosing spondylitis	0.000684	0.00117	CcSEcCtD
Paricalcitol—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000684	0.00117	CcSEcCtD
Paricalcitol—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000684	0.00117	CcSEcCtD
Paricalcitol—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000684	0.00117	CcSEcCtD
Paricalcitol—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000684	0.00117	CcSEcCtD
Paricalcitol—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000683	0.00116	CcSEcCtD
Paricalcitol—Insomnia—Prednisone—ankylosing spondylitis	0.000682	0.00116	CcSEcCtD
Paricalcitol—Paraesthesia—Prednisone—ankylosing spondylitis	0.000677	0.00115	CcSEcCtD
Paricalcitol—Pruritus—Triamcinolone—ankylosing spondylitis	0.000675	0.00115	CcSEcCtD
Paricalcitol—Cough—Methotrexate—ankylosing spondylitis	0.000673	0.00115	CcSEcCtD
Paricalcitol—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000673	0.00115	CcSEcCtD
Paricalcitol—Dyspepsia—Prednisone—ankylosing spondylitis	0.000663	0.00113	CcSEcCtD
Paricalcitol—Chest pain—Methotrexate—ankylosing spondylitis	0.000657	0.00112	CcSEcCtD
Paricalcitol—Myalgia—Methotrexate—ankylosing spondylitis	0.000657	0.00112	CcSEcCtD
Paricalcitol—Arthralgia—Methotrexate—ankylosing spondylitis	0.000657	0.00112	CcSEcCtD
Paricalcitol—Decreased appetite—Prednisone—ankylosing spondylitis	0.000655	0.00112	CcSEcCtD
Paricalcitol—Rash—Prednisolone—ankylosing spondylitis	0.000654	0.00111	CcSEcCtD
Paricalcitol—Dermatitis—Prednisolone—ankylosing spondylitis	0.000653	0.00111	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000652	0.00111	CcSEcCtD
Paricalcitol—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000651	0.00111	CcSEcCtD
Paricalcitol—Fatigue—Prednisone—ankylosing spondylitis	0.00065	0.00111	CcSEcCtD
Paricalcitol—Headache—Prednisolone—ankylosing spondylitis	0.00065	0.00111	CcSEcCtD
Paricalcitol—Discomfort—Methotrexate—ankylosing spondylitis	0.000649	0.00111	CcSEcCtD
Paricalcitol—Constipation—Prednisone—ankylosing spondylitis	0.000644	0.0011	CcSEcCtD
Paricalcitol—Confusional state—Methotrexate—ankylosing spondylitis	0.000635	0.00108	CcSEcCtD
Paricalcitol—Dizziness—Triamcinolone—ankylosing spondylitis	0.000631	0.00107	CcSEcCtD
Paricalcitol—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000629	0.00107	CcSEcCtD
Paricalcitol—Infection—Methotrexate—ankylosing spondylitis	0.000626	0.00107	CcSEcCtD
Paricalcitol—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000621	0.00106	CcSEcCtD
Paricalcitol—Asthenia—Betamethasone—ankylosing spondylitis	0.000621	0.00106	CcSEcCtD
Paricalcitol—Asthenia—Dexamethasone—ankylosing spondylitis	0.000621	0.00106	CcSEcCtD
Paricalcitol—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000618	0.00105	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000616	0.00105	CcSEcCtD
Paricalcitol—Nausea—Prednisolone—ankylosing spondylitis	0.000616	0.00105	CcSEcCtD
Paricalcitol—Pruritus—Betamethasone—ankylosing spondylitis	0.000612	0.00104	CcSEcCtD
Paricalcitol—Pruritus—Dexamethasone—ankylosing spondylitis	0.000612	0.00104	CcSEcCtD
Paricalcitol—Skin disorder—Methotrexate—ankylosing spondylitis	0.000612	0.00104	CcSEcCtD
Paricalcitol—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000609	0.00104	CcSEcCtD
Paricalcitol—Vomiting—Triamcinolone—ankylosing spondylitis	0.000606	0.00103	CcSEcCtD
Paricalcitol—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000605	0.00103	CcSEcCtD
Paricalcitol—Rash—Triamcinolone—ankylosing spondylitis	0.000601	0.00102	CcSEcCtD
Paricalcitol—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000601	0.00102	CcSEcCtD
Paricalcitol—Anorexia—Methotrexate—ankylosing spondylitis	0.0006	0.00102	CcSEcCtD
Paricalcitol—Rash—Methylprednisolone—ankylosing spondylitis	0.0006	0.00102	CcSEcCtD
Paricalcitol—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000599	0.00102	CcSEcCtD
Paricalcitol—Urticaria—Prednisone—ankylosing spondylitis	0.000599	0.00102	CcSEcCtD
Paricalcitol—Headache—Triamcinolone—ankylosing spondylitis	0.000597	0.00102	CcSEcCtD
Paricalcitol—Headache—Methylprednisolone—ankylosing spondylitis	0.000596	0.00102	CcSEcCtD
Paricalcitol—Abdominal pain—Prednisone—ankylosing spondylitis	0.000596	0.00102	CcSEcCtD
Paricalcitol—Body temperature increased—Prednisone—ankylosing spondylitis	0.000596	0.00102	CcSEcCtD
Paricalcitol—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000592	0.00101	CcSEcCtD
Paricalcitol—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000592	0.00101	CcSEcCtD
Paricalcitol—Hypotension—Methotrexate—ankylosing spondylitis	0.000589	0.001	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000574	0.000978	CcSEcCtD
Paricalcitol—Dizziness—Dexamethasone—ankylosing spondylitis	0.000572	0.000975	CcSEcCtD
Paricalcitol—Dizziness—Betamethasone—ankylosing spondylitis	0.000572	0.000975	CcSEcCtD
Paricalcitol—Insomnia—Methotrexate—ankylosing spondylitis	0.00057	0.000971	CcSEcCtD
Paricalcitol—Nausea—Triamcinolone—ankylosing spondylitis	0.000567	0.000966	CcSEcCtD
Paricalcitol—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000566	0.000964	CcSEcCtD
Paricalcitol—Nausea—Methylprednisolone—ankylosing spondylitis	0.000565	0.000963	CcSEcCtD
Paricalcitol—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000562	0.000957	CcSEcCtD
Paricalcitol—Somnolence—Methotrexate—ankylosing spondylitis	0.00056	0.000954	CcSEcCtD
Paricalcitol—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000555	0.000946	CcSEcCtD
Paricalcitol—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000554	0.000945	CcSEcCtD
Paricalcitol—Vomiting—Betamethasone—ankylosing spondylitis	0.00055	0.000938	CcSEcCtD
Paricalcitol—Vomiting—Dexamethasone—ankylosing spondylitis	0.00055	0.000938	CcSEcCtD
Paricalcitol—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000548	0.000933	CcSEcCtD
Paricalcitol—Rash—Dexamethasone—ankylosing spondylitis	0.000546	0.00093	CcSEcCtD
Paricalcitol—Rash—Betamethasone—ankylosing spondylitis	0.000546	0.00093	CcSEcCtD
Paricalcitol—Dermatitis—Betamethasone—ankylosing spondylitis	0.000545	0.000929	CcSEcCtD
Paricalcitol—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000545	0.000929	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000544	0.000927	CcSEcCtD
Paricalcitol—Fatigue—Methotrexate—ankylosing spondylitis	0.000543	0.000926	CcSEcCtD
Paricalcitol—Headache—Betamethasone—ankylosing spondylitis	0.000542	0.000924	CcSEcCtD
Paricalcitol—Headache—Dexamethasone—ankylosing spondylitis	0.000542	0.000924	CcSEcCtD
Paricalcitol—Asthenia—Prednisone—ankylosing spondylitis	0.000541	0.000922	CcSEcCtD
Paricalcitol—Pain—Methotrexate—ankylosing spondylitis	0.000539	0.000918	CcSEcCtD
Paricalcitol—Pruritus—Prednisone—ankylosing spondylitis	0.000533	0.000909	CcSEcCtD
Paricalcitol—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000519	0.000885	CcSEcCtD
Paricalcitol—Diarrhoea—Prednisone—ankylosing spondylitis	0.000516	0.000879	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000515	0.000878	CcSEcCtD
Paricalcitol—Nausea—Betamethasone—ankylosing spondylitis	0.000514	0.000876	CcSEcCtD
Paricalcitol—Nausea—Dexamethasone—ankylosing spondylitis	0.000514	0.000876	CcSEcCtD
Paricalcitol—Urticaria—Methotrexate—ankylosing spondylitis	0.0005	0.000853	CcSEcCtD
Paricalcitol—Dizziness—Prednisone—ankylosing spondylitis	0.000498	0.000849	CcSEcCtD
Paricalcitol—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000498	0.000849	CcSEcCtD
Paricalcitol—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000498	0.000849	CcSEcCtD
Paricalcitol—Vomiting—Prednisone—ankylosing spondylitis	0.000479	0.000817	CcSEcCtD
Paricalcitol—Rash—Prednisone—ankylosing spondylitis	0.000475	0.00081	CcSEcCtD
Paricalcitol—Dermatitis—Prednisone—ankylosing spondylitis	0.000475	0.000809	CcSEcCtD
Paricalcitol—Headache—Prednisone—ankylosing spondylitis	0.000472	0.000805	CcSEcCtD
Paricalcitol—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000464	0.000791	CcSEcCtD
Paricalcitol—Asthenia—Methotrexate—ankylosing spondylitis	0.000452	0.00077	CcSEcCtD
Paricalcitol—Nausea—Prednisone—ankylosing spondylitis	0.000448	0.000763	CcSEcCtD
Paricalcitol—Pruritus—Methotrexate—ankylosing spondylitis	0.000446	0.00076	CcSEcCtD
Paricalcitol—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000431	0.000735	CcSEcCtD
Paricalcitol—Dizziness—Methotrexate—ankylosing spondylitis	0.000416	0.00071	CcSEcCtD
Paricalcitol—Vomiting—Methotrexate—ankylosing spondylitis	0.0004	0.000683	CcSEcCtD
Paricalcitol—Rash—Methotrexate—ankylosing spondylitis	0.000397	0.000677	CcSEcCtD
Paricalcitol—Dermatitis—Methotrexate—ankylosing spondylitis	0.000397	0.000676	CcSEcCtD
Paricalcitol—Headache—Methotrexate—ankylosing spondylitis	0.000395	0.000673	CcSEcCtD
Paricalcitol—Nausea—Methotrexate—ankylosing spondylitis	0.000374	0.000638	CcSEcCtD
